Yishai Zohar is the founder of Gelesis. Gelesis has raised $100M in total funding. Latest round: Series D. Backed by Vitruvian Partners.
Yishai Zohar is the founder and Chief Executive Officer of Gelesis, a biotechnology company based in Boston, MA. Gelesis develops a novel hydrogel platform technology aimed at treating obesity and other chronic gastrointestinal diseases. The company recently secured over $84 million in new capital, including a $63.4 million equity round led by Vitruvian Partners, to support the US launch of its product, Plenity.
Full founder directory · Investor directory · Company funding database · Fundraising library